Reference Medicine

2 known investors

Reference Medicine supplies quality-controlled human oncology specimens to research teams, sourcing samples across cancer indications from IRB/EC-accredited institutions worldwide. It provides an inventory with upfront per-specimen pricing and lets customers mix and match products to build the cohorts they need.